Evidence map›Paper›PMID 26563584›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Development of Genetic Dereplication Strains in Aspergillus nidulans Results in the Discovery of Aspercryptin.

Yi-Ming Chiang, Manmeet Ahuja, C Elizabeth Oakley, Ruth Entwistle, Anabanadam Asokan, Christoph Zutz, Clay C C Wang, Berl R Oakley

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Genetic Dereplication of MultipleJournal of natural products · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Heterologous expression of anChemical science · 2025
    Article
  10. Biosynthesis Regulation of Secondary Metabolite Production inJournal of fungi (Basel, Switzerland) · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Transcription Factor Engineering inJournal of natural products · 2024
    Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi-Ming ChiangDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.ORCID http://orcid.org/0000-0001-9899-1364
Manmeet AhujaDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
C Elizabeth OakleyDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Ruth EntwistleDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA.
Anabanadam AsokanDel Shankel Structural Biology Center, University of Kansas, Lawrence, KS, 66045, USA.
Christoph ZutzInstitute for Milk Hygiene, University of Veterinary Medicine Vienna, Vienna, 1210, Austria.
Clay C C WangDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.
Berl R OakleyDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66045, USA. boakley@ku.edu.ORCID http://orcid.org/0000-0002-3046-8240

Funding

Molecular Genetic Mining of the Aspergillus Nidulans Secondary MetabolomeP01GM084077 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OAKLEY, BERL RAY · 2008 to 2012
$5.4M
NIGMS NIH HHS P01 GM084077NIGMS NIH HHS P01-GM084077
6 · The paper itself

Abstract

To reduce the secondary metabolite background in Aspergillus nidulans and minimize the rediscovery of compounds and pathway intermediates, we created a "genetic dereplication" strain in which we deleted eight of the most highly expressed secondary metabolite gene clusters (more than 244,000 base pairs deleted in total). This strain allowed us to discover a novel compound that we designate aspercryptin and to propose a biosynthetic pathway for the compound. Interestingly, aspercryptin is formed from compounds produced by two separate gene clusters, one of which makes the well-known product cichorine. This raises the exciting possibility that fungi use differential regulation of expression of secondary metabolite gene clusters to increase the diversity of metabolites they produce.

Indexed as

Aspergillus nidulansChromatography, High Pressure LiquidGenes, FungalOligopeptidesaspercryptinOligopeptidesaspergillusbiosynthesisgenetic dereplicationnatural productsNRPS

Identifiers

PMID26563584
PMCPMC4724294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.